SOLGEN Trademark
Trademark Overview
On Tuesday, March 11, 2003, a trademark application was filed for SOLGEN with the United States Patent and Trademark Office. The USPTO has given the SOLGEN trademark a serial number of 78224067. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Saturday, March 27, 2004. This trademark is owned by National Association of Senior Friends. The SOLGEN trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:
Providing lifestyle and health information and resources to adults over 50 years of age.
General Information
| Serial Number | 78224067 |
| Word Mark | SOLGEN |
| Filing Date | Tuesday, March 11, 2003 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Saturday, March 27, 2004 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Providing lifestyle and health information and resources to adults over 50 years of age. |
Classification Information
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, March 31, 2003 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | National Association of Senior Friends |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Nashville, TN 37202 |
Trademark Events
| Event Date | Event Description |
| Saturday, March 27, 2004 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Monday, August 25, 2003 | NON-FINAL ACTION E-MAILED |
| Monday, August 25, 2003 | ASSIGNED TO EXAMINER |
